VIDAL Group Acquires Agence C.C.C., a Quality French Medical Events Agency ~ M3 Group Expands into Medical Events Sector for General Practitioners ~

[FY2024 Q2] Summary of Consolidated Financial Results

[FY2024 Q2] M3 Presentation Material

[Abridged] Announcement Concerning Results of Tender Offer for Shares of ELAN Corporation (Securities Code: 6099) and the Change in Subsidiary

M3’s Subsidiary CUC to Acquire Shares in Noah Konzer Co.,Ltd Which Operates Nursing Home in Sapporo to Make It The Consolidated Subsidiary

Capital and Business Alliance with ELAN Corporation

Notice Concerning Commencement of Tender Offer for Shares of ELAN Corporation (Securities Code: 6099), and Execution of Capital and Business Tie-up Agreement

[FY2024 Q1] Summary of Consolidated Financial Results

[FY2024 Q1] M3 Presentation Material

M3’s Subsidiary Cosmotec to Enter into Capital and Business Alliance with French Medical Device Startup, Sensome ~ Entry into the Neurosurgery Field by Acquisition of Exclusive Distribution Rights ~

White Jack Project Phase 7; M3 consolidates MinaCare, Which Provides Health Business Support Services ～ Accelerates Service Expansion for Health Insurance Associations ～

Matters Related to Controlling Shareholders, etc.

[FY2023 Q4] Summary of Consolidated Financial Results

[FY2023 Q4] Summary of Consolidated Financial Results; Full-Page Translated Version

[FY2023 Q4] M3 Presentation Material

Notice Concerning Differences between Actual Non-Consolidated Results for the Fiscal Year Ended March 31, 2024 and the Previous Fiscal Year Ended March 31, 2023

White Jack Project Phase 6; M3 consolidates Medcare, Which Provides Lifestyle Improvement Services ～ Expands Services for Health Insurance Associations to fulfill M3’s Mission ～

M3 consolidates Infrastructure for On Call Cooperation, Which Provides “Buddy On Call™”, House Call Agency Service during Nights and Holidays, for Medical Institutions ～Aiming to Build Infrastructure for Home Medical Care in Japan～

Announcement of Receipt of Dividends from Consolidated Subsidiaries

Notice Concerning Result of Tender Offer for Shares of Benefit One Inc. (Securities Code: 2412)

Notice of Amendment to Dividend Payout Forecast

Notice Regarding Change of Opinion of Benefit One Inc. for Tender Offer for Shares of Benefit One Inc. (Securities Code: 2412) and Extension of Tender Offer

Notice Regarding Change of Opinion of Benefit One Inc. for Tender Offer for Shares of Benefit One Inc. (Securities Code: 2412)

M3’s Subsidiary M3 Solutions to Enter into Capital Alliance with Atmark Inc Which Develops Automated Human Resources Matching System “arroba” ～Accelerating Staffing Services of Clinic DX Professionals～

[FY2023 Q3] Summary of Consolidated Financial Results

[FY2023 Q3] M3 Presentation Material

Notification of Extension of Tender Offer to Acquire Common Shares of Benefit One Inc.

M3’s Subsidiary CUC to Acquire Membership Interests in Albaron Podiatry Holdings, LLC Which Owns and Operates a Podiatry Service Platform under the Name of ‘Beyond Podiatry’

Notification of Extension of Tender Offer to Acquire Common Shares of Benefit One Inc.

M3 consolidates DBMCI to Advance Classroom-Based courses for Medical PG Preparation ~ Strengthening Education Service for Doctors and Medical Students in India ~

Notice Concerning Commencement of Tender Offer for Shares of Benefit One Inc. (Securities Code: 2412), and Execution of Capital and Business Tie-up Agreement

Capital and Business Alliance with Benefit One Inc.

[FY2023 Q2] Summary of Consolidated Financial Results

[FY2023 Q2] M3 Presentation Material

Notice of Application for the Tender Offer for the Shares of and Future Capital Alliance with Visionary Holdings Co., Ltd.

M3 Acquires DrSanté, a Fast-Growing Practice Management Software in France ~ Strengthening M3's Position as a Leading Provider in Ambulatory Care ~

M3 Acquires Messly, Leading Physician Recruiting Platform in the U.K. ~ Strengthening M3 Group's Ability to Address Staffing Shortages ~

M3 Acquires Frogwell, a Salesforce Consulting Service Provider in Japan ~ Accelerate the DX of Sales and Marketing Initiatives in the Healthcare Industry ~

[FY2023 Q1] Summary of Consolidated Financial Results

[FY2023 Q1] M3 Presentation Material

Final Agreement Concluded to Acquire Kantar’s Specialist Healthcare Research Businesses ~ Expansion of M3’s Global Healthcare Panel and Research Services ~

Acquisition of Kantar’s Two Healthcare Research Divisions -Supplemental Material -

Notice of Listing Approval of Consolidated Subsidiary (CUC Inc.)

[FY2022 Q4] Summary of Consolidated Financial Results

[FY2022 Q4] M3 Presentation Material

[FY2022 Q4] Summary of Consolidated Financial Results; Full-Page Translated Version

Notice Concerning Differences Between the Actual Consolidated Results for the Fiscal Year Ended March 31, 2023 versus the Respective Previous Fiscal Year

M3 Acquires Scribendi Inc. in Canada ~ Strengthen Research Paper Editing Platform and Accelerate its Globalization ~

M3 Acquires Med Planet in France ~ M3 Continues to Strengthen Capabilities and Reach with Latest French Acquisition ~

White Jack Project Phase 5: Merge of Happiness-i and Rinkai Medical Service ~"M3 Health Design" will play a central role in the White Jack Project ~

Notice of Amendment to Dividend Payout

Positive top-line results in Phase III studies of FSN-013

[FY2022 Q3] M3 Presentation Material

M3 Acquires Michael Allen Company in the U.S. ~ Strengthen Global Relationships with Pharmaceutical Companies ~

[FY2022 Q3] Summary of Consolidated Financial Results

M3 Acquires Remedium in the U.K. ~ New Entry into International Physician Recruiting Business ~

[FY2022 Q2] Summary of Consolidated Financial Results

[FY2022 Q2] M3 Presentation Material

White Jack Project Phase 4, 'EBHS Life' launched; New health indicator ~ Predicting relative life expectancy based on the results of health check-ups and lifestyle habits, promoting health management and improving the health of consumers ~

Full launch of M3 Cancer Prevention Program for Corporations ～3rd phase of the White Jack Project: Accelerating measures to combat a national disease affecting 1 out of 2 people～

M3 Acquires Rinkai Medical Service, Health Checkup Service Provider ~ Further initiative in the field of preventive medicine as Phase 2 of “White-Jack Project” ~

"RECELL® Autologous Cell Harvesting Device" Insurance Coverage Begins in Japan ~ Medical Device for Acute Burns and Donor Sites ~

[FY2022 Q1] M3 Presentation Material

[FY2022 Q1] Summary of Consolidated Financial Results

M3 Launches “White-Jack Project,” an Initiative in the Field of Preventive Medicine ~ Acquiring Health Checkup Service Provider, Happiness-i, as Project Phase1 ~

M3 acquires iDoctus, the leading HCP point-of-care mobile app operator in Spain, Mexico and rest of Latin America ~ Addition of widely used point-of-care app expands M3’s presence in key Spanish speaking regions ~

M3 Acquires pharma-insight GmbH in Germany ~ M3 Continues to Strengthen Capabilities and Panel with German Acquisition ~

M3 acquires U.S. Multi-Specialty Clinical Research Site ~ Expanding M3-Wake Research’s coverage to Florida ~

Notice Concerning Differences Between Actual Consolidated and Non-consolidated Results for the Fiscal Year Ended March 31, 2022 versus the Respective Previous Fiscal Year

[FY2021 Q4] M3 Presentation Material

[FY2021 Q4] Summary of Consolidated Financial Results

M3 Acquires Medical Accounting and EHR Business from Canon Medical Systems ~ Accelerating DX of Clinics along with M3 DigiKar, the No.1 Share Cloud EHR System ~

Launch of “Clinic Succession Platform” for Third-Party Accedence of Clinics ~ m3.com Platform to Support Sustainability of Medical Institutions Across Generations ~

Donation to Support Relief Activities in Ukraine ~ JPY 12,051,200 in Combined Donations from m3.com Members, Matched by M3 ~

M3 to Acquire Logic Inc. ~ Digital Transformation of Home Medical Care via SaaS for Nursing Care Facilities ~

"RECELL® Autologous Cell Harvesting Device" Gains Regulatory Approval in Japan ~ Medical Device for Acute Burns and Donor Sites ~

Notice of Amendment to Dividend Payout Forecast

M3 Acquires MirVracha LCC in Russia ~ Launching Full-Scale Development of Physician Platform Business in Russia ~

[FY2021 Q3] M3 Presentation Material

[FY2021 Q3] Summary of Consolidated Financial Results

M3 to Acquire 3H Holdings and Three Other Group Companies ~ Leading a next-generation clinical trial area leveraging largest patient recruitment panels ~

Launch of "Patient Centricity Promotion Center" ~ Patient-centric Drug Development by Mediscience Planning and QLife ~

French CME Provider ERON Santé Becomes Part of VIDAL Group ~ Becoming a Leading Provider of Online Continuing Medical Education ~

M3 Acquires Ekas Marketing in Australia ~ M3 Continues Expansion of Global Physician Coverage with Australian Acquisition ~

Notice of Selection of Prime Market in Tokyo Stock Exchange New Market Segments

Transfer of Shares of TamaBio to Quon Capital ~ TamaBio: Manufacturer of Artificial Biomembranes for Neurosurgery and Cardiac Surgery ~

“Medical Marketer” Service Tops Adoption by Over 100 Drugs ~ “Remote x Data x Personnel Pharma” Sales and Marketing Productivity Support Service ~

[FY2021 Q2] M3 Presentation Material

[FY2021 Q2] Summary of Consolidated Financial Results

No.1 Cloud Based EMR System “M3 DigiKar” Tops 3000 Clinic Adoptions ~ Medical Field DX Acceleration with “M3 DigiKar Smart” ~

[FY2021 Q1] M3 Presentation Material

[FY2021 Q1] Summary of Consolidated Financial Results

Recognition of Dilution Gains from Changes in Equity Interest Mainly Related to Medlive's Listing in Hong Kong

Capital Alliance with Epigno Co., Ltd ~ Accelerate DX of Talent Management for Medical Institutions ~

Pfizer On-boards Entire Sales Rep Force onto M3’s myMR-kun ~ Two-Way Digitalized Information Provision via Remote Detailing System ~

Announcement Regarding the Recognition of Gain Relating to Loss of Control Over Subsidiaries

M3 Acquires Stake in pA Medien GmbH to Expand Germany Business Platform ~ Investment in praktischArzt, the Leading Online Physician Recruitment Job Board in Germany ~

[FY2020 Q4] M3 Presentation Material

Notice Concerning Differences Between Actual Consolidated and Non-consolidated Results for the Fiscal Year Ended March 31, 2021 versus the Respective Previous Fiscal Year

[FY2020 Q4] Summary of Consolidated Financial Results

Launch of Cashless Payment System for Medical Facilities ~ Joint Effort Between ©Stripe and “M3 DigiKar,” the No.1 Cloud Based EHR System in Japan ~

Joint Development of Disease Awareness Service with Takeda ~ HAE Disease Awareness System on AskDoctors ~

M3 Acquires One Health Communications Holdings ~ Extending Capabilities and Reach Across UK Healthcare Professionals ~

m3.com Physician Membership Tops 300,000 in Japan ~ Launching M3-Labo Under “More Contributions to More Doctors” ~

Capital Alliance with Africa Health Holdings Limited ~ Solution for Medical Facilities, Pharmacies and Laboratories in Africa ~

Notice of Amendment to Dividend Payout Forecast

M3 to Merge Subsidiaries Mediscience Planning and MIC Medical ~ Acceleration in Optimizing Digitalized Clinical Trials ~

Free Provision of Entertainment Robot “aibo” to Medical Facilities ~ Stress Relief for Hospitalized COVID-19 Patients ~

[FY2020 Q3] M3 Presentation Material

[FY2020 Q3] Summary of Consolidated Financial Results

M3 Acquires TOWA SANGYO Co., Ltd. ~ DX Acceleration in the Medical Device Industry ~

Vidal Holding France Acquires MonEcho, an AI-Assisted Sonogram Software Company ~ Expansion into Ob-Gyns and Cardiology Therapy Areas in France ~

LINE Healthcare Launches Free “LINE Doctor” in Greater Tokyo Area ~ Service Region to Expand with Improvements ~

SONY and M3 Join Forces for Open Innovation Projects in Healthcare ~ Collaborative Medical Practice Advancement for Social Solutions ~

M3 and Nippon Boehringer Ingelheim enter into a business partnership for diagnostic support utilizing Artificial Intelligence (AI) for ILDs and other lung diseases

Joint Development and Distribution Agreement with Fuji Pharma ~ Collaboration of Capabilities for End-to-end Solutions ~

[FY2020 Q2] M3 Presentation Material

[FY2020 Q2] Summary of Consolidated Financial Results

No.1 Cloud Based EMR System “M3 DigiKar” Tops 2000 Clinic Adoptions ~ Managing Medical Records of Over 36 Million Patients ~

COVID-19 Pneumonia AI Free Provision Project Expansion and Exacerbation Prediction AI Development

LHC's Online Examination Service "LINE Doctor" to be Launched in November ~ FREE One-Click Clinic Search & Appointment, Consultation, and Payment Service via LINE ~

M3 to Construct New Communication Platform with Takeda ~ New Communication Function Development Based on myMR-kun ~

[FY2020 Q1] Summary of Consolidated Financial Results

M3 Wake Research to be Among the First Sites to Conduct Moderna's COVID-19 Vaccine Study in the US

[FY2020 Q1] M3 Presentation Material

AI Medtech "COVID-19 Pneumonia Image Analysis Program Ali-M3" Gains Approval for Manufacturing & Sales, Launches Distribution

Astellas On-boards Entire Sales Rep Force onto M3's myMR-kun ~ Acceleration of Digital Transformation via Remote Detailing System ~

DOCOMO, M3, and SONY Join Forces for ICT/IoT Integration in Healthcare ~ First COVID-19 Project: VR/AR Integrated "Virtual Excursions" for Hospitalized Patients ~

Dramatic Increase in M3PSP® (Patient Support Program®) Users ~ NPS® Remains Lofty at +77 via Unsurpassed Satisfaction Provision ~

[FY2019] M3 Presentation Material

[FY2019] Summary of Consolidated Financial Results

Gunze Group to Distribute Seeds Rocket Product DurabeamTM ~ Increased Presence in Neurosurgical Therapy Area ~

COVID-19 Real Time Report Launch: Patient Activity ~ Number of Patient Visits Drop 50% for Some Therapy Areas Post COVID-19~

Launch of AI Medical Image Diagnostics Platform Business ~ Business Alliance Agreement with NOBORI ~

Full Scale Roll Out of CVC "1Y1P Fund" ~ Dedicated Website Launched to Fortify Investment Activity ~

Dramatic Increase in Activity on m3.com ~ Visit Duration +38%, eDetail Reads +56%, Webinar Viewers +76% ~

SONY and M3 Announces Collaboration on COVID-19 Measures

LINE Healthcare: Free Online Health Consultations Extended Into April Amidst COVID-19 ~ Increasing Online Consultations Leading to Reduction of Unnecessary Hospital Visits~

M3 and St. Marianna University School of Medicine Hospital to Launch COVID-19 Remote Image Diagnosis Support ~ Collaboration with Alibaba and NOBORI ~

M3 to Purchase Huma's Clinical Trial Patient Recruitment Asset ~ Becoming the Industry's Largest Patient Recruitment Organization (PRO) ~

M3 Acquires Manthan's Healthcare Market Research Business ~ Fortification of Client Base, Physician Panel, and Operations in N. America and Europe out of India~

Joint AI Dissertation by M3, Tokyo U., and Keio U., Accepted at US's AAAI Conference ~ Medical AI Software Systems Development and Implementation Classification ~

Industry Wide M3 Initiatives to Combat COVID-19 ~ Solutions for the General Public, Medical Professionals, and Pharmaceutical Companies ~

LINE Healthcare: Adopted to Support METI's Health Consultation Hotline ~ Free Online Consultations on LINE Healthcare, Supported by 1,000 m3.com Physicians ~

LINE Healthcare: Feb Consultations Increase 40x vs. Jan, Total Users Top 4 Million ~ Over 50% of Consultations Regarding COVID-19, Over 70% "Satisfied" Users ~

M3 USA Acquires NAS Recruitment Innovation ~ Leader in Healthcare Digital Solutions Expands Portfolio to Include Recruitment Marketing ~

Capital Alliance with Kringle Pharma, Inc. ~ 7P Initiative: Development of Therapeutic Drugs for Spinal Cord Injury ~

LINE Healthcare Joint Project with Novartis: Official Account for Hay Fever ~ Online Symptoms Checker, Doctor Consultations, and Hospital Search & Reservations ~

National Cancer Center Hospital and M3 to Promote Regionalized Medical Care ~ Functionalization in Cancer Care via Provision of Latest Cancer Treatment Information ~

[FY2019 Q3] Summary of Consolidated Financial Results

[FY2019 Q3] M3 Presentation Material

JMA and M3 Announce Agreement on Comprehensive Partnership ~ Pilot Business for Third-Party Private Practice Successions~

Beta Launch of LINE Healthcare for iOS, a Consumer Healthcare Platform ~ Providing Access to Reliable and Timely Online Remote Consultations ~

Beta Launch of LINE Healthcare for Android, a Consumer Healthcare Platform ~ Providing Access to Reliable and Timely Online Remote Consultations ~

Capital Alliance with VisionaryHoldings Co., Ltd. ~ 7P Project: Holistic Solutions for Issues Surrounding Ophthalmologic Diseases ~

[FY2019 Q2] Summary of Consolidated Financial Results

Launch of Internal Corporate Venture Capital Fund "1P1Y (1 Person 1 Yen) Fund" ~ Acceleration of 7P Projects through 10 Billion Yen Investment ~

[FY2019 Q2] M3 Presentation Material

M3 and Shionogi Joint Venture for Disease Solutions ~Establishment of Stream-I, Inc.~

Acquisition of Largest French Cloud Based Electronic Health Record Company ~ 50%+ SaaS EHR Market Share, Housing Over 25 Million Patient Records ~

Capital Alliance with Lily MedTech ～ 7P Project: Painless Breast Cancer Diagnostic Device Development～

[FY2019 Q1] M3 Presentation Material

[FY2019 Q1] Summary of Consolidated Financial Results

Consolidation of EDANZ GROUP JAPAN ~ Cloud Sourcing Global Medical Researchers to Support Medical Paper Publications ~

[FY2018 Q4] M3 Presentation Material　

[FY2018] Summary of Consolidated Financial Results

Notice of Amendment to Dividend Payout Forecast

Consolidation of DailyRounds, Inc.: Indian Communities for Doctors and Med Students ~ Entry into Med-ucation Services with 450,000 Members, Proportionate to Half of all Doctors in India ~

Consolidation of INDEE Medical Inc. (Project Code: A2-3) ~ Entry into Dermatology, Plastics, and Emergency Therapy via New Treatment Device ~

DOCOMO and M3 Enters Into Capital and Business Partnership ~Establishment of empheal inc. to Support Corporate Health Management

Notice of Issuance of New Shares by Third-Party Allotment

Notice of Acquisition and Consolidation of Nihon Ultmarc. INC.

[FY2018 Q3] Summary of Consolidated Financial Results

[FY2018 Q3] M3 Presentation Material

LINE and M3 Launch an Online Healthcare Business Company ~ Joint Investment in Establishment of "LINE Healthcare Corporation" ~

Pericardium Sheet "PeriBeam®" Production and Distribution Approval in Japan ~ Second M3 Launch of Riken Product Series Following DuraBeam® ~

Roll Out of AI Assisted Cloud Based EMR System "M3 DigiKar" ~ Number of Managed Medical Records to Top 10 Million by Year End ~

[FY2018 Q2] Summary of Consolidated Financial Results

[FY2018 Q2] M3 Presentation Material

Acquisition of U.S. Clinical Trial Execution Facility ~ Three Additional Sites in California, Increased Access to 50 Thousand New Patients ~

Consolidation of Shin Nippon Biomedical Laboratories, Ltd. 　 ~ Becoming the Industry Top Class SMO ~

Consolidation of Y's, Inc. ~ Innovation in Stroke Rehabilitation Care Provision ~

Disease Specific Solution Provision - Consolidation of Y's, Inc. - (Reference Materials)

[FY2018 Q1] Summary of Consolidated Financial Results

Announcement of Two-for-One Stock Split

[FY2018 Q1] M3 Presentation Material

Development of AI Diagnostics Open Platform "Doc+AI" ~ Making Various AI Algorithms for Imaging Diagnostics Available ~

AI Alliance between M3 and DEEPCORE ~ Launch of Medical A.I. Business Development Support Program ~

[FY2017] M3 Presentation Material

[FY2017] Summary of Consolidated Financial Results

Notice of Amendment to Dividend Payout Forecast

Consolidation of US Clinical Trial Support Company, Wake Research~ Entering the Clinical Trial Business in the U.S. ~

NVIDIA and M3 Collaboration in "Medical x AI Inception Program" Launch ~ Comprehensive Support Program for the Development of Medical Artificial Intelligence ~

Acquisition of Sophiamedi Corp.~ Catering to a Super Aging Society Through Business Development in Home Nursing Care ~

[FY2017 Q3] M3 Presentation Material

[FY2017 Q3] Summary of Consolidated Financial Results

Consolidation of Swedish Research Firm, QQFS ~ Further Expansion of M3's European Physician Membership Panel ~

Capital Alliance with Genomix Co., Ltd. (Project Code: B2-1) ~ Expansion of 3rd Growth Driver Initiatives in Advanced Medicine: Regenerative Medicine ~

Physician Membership Tops 2 Million in China ~ Number of Active Users Up 58%, China Operating Profit Increased Over 10x vs. Previous Year ~

Acquisition of JAMECS Inc. ~ Further Development of M3's Advanced Medicine Platform Through Expansion in Opthalmology ~

[FY2017 Q2] M3 Presentation Material

[FY2017 Q2] Summary of Consolidated Financial Results

Notice of Acquisition of COSMOTEC - Reference Material

RIKEN Medical Technology Seed Development at M3 Group Artificial Dura Mater "DuraBeamTM" Production and Distribution Approval in Japan

[FY2017 Q1] Summary of Consolidated Financial Results

[FY2017 Q1] M3 Presentation Material

[FY2016 Q4] M3 Presentation Material

[FY2016 Q4] Summary of Consolidated Financial Results

Notice of Amendment to Dividend Payout Forecast

Acquisition of RotaMaster In the U.K. ~ A Momentous Step for Market Entry into the UK Career Business ~

[FY2016 Q3] M3 Presentation Material

[FY2016 Q3] Summary of Consolidated Financial Results

Acquisition of iG-Holdings Inc. ~ M3 Group Now Top Class in Healthcare Advertisement Agency Industry ~

Notice Regarding the Completion of the Acquisition of Shares and Consolidation of AXIO Medical Holdings Limited

[FY2016 Q2] Summary of Consolidated Financial Results

[FY2016 Q2] M3 Presentation Material

Amendment made to [FY2016 Q1] M3 Presentation Material (pg. 9)

Notice Regarding the Acquisition of Shares and Consolidation of AXIO Medical Holdings Limited

M3 Consolidation of Vidal Group Presentation Material

Acquisition of Anestation,Ltd. ~ Acceleration of Free Agent Physician Placement Business Through Addition of a Growth Engine Based in Kansai ~

Notice Regarding the Launch of the Joint Venture in India

[FY2016 Q1] M3 Presentation Material

[FY2016 Q1] Summary of Consolidated Financial Results ...

Capital Alliance with TECOM Group ~ Maximizing M3's Membership Base and TECOM Group's Educational Content to Launch an Education Business Targeting Medical Professionals ~

Capital Alliance with Human Metabolome Technologies ~ Joint Development of Innovative Biomarkers in Effort to Advance Personalized Medicine ~

[FY2015 Q4] Summary of Consolidated Financial Results

[FY2015 Q4] M3 Presentation Material

Seeds Rocket Business Launch ~ Initial Seed: MedTecHeart's Next Generation Artificial Heart Development ~

Notice of Amendment to Dividend Payout Forecast

[FY2015 Q3] Summary of Consolidated Financial Results

[FY2015 Q3] M3 Presentation Material

Acquisition of QLife, Inc.~Becoming Top Class in Healthcare Media for Consumers ~

Further Acquisitions for the Career Business at M3 USA

Physician Membership Tops 2.5 Million Members in Key Five Regions, 3.4 Million Globally

[FY2015 Q2] Summary of Consolidated Financial Results

[FY2015 Q2] M3 Presentation Material

[FY2015 Q1] M3 Presentation Material

[FY2015 Q1] Summary of Consolidated Financial Results

[FY2014 Q4] Summary of Consolidated Financial Results

[FY2014 Q4] M3 Presentation Material

Notice of Amendment to Dividend Payout Forecast

M3 USA Acquires New England Physician Recruitment Center

M3 to Acquire Integrated Development Associates

[FY2014 Q3] M3 Presentation Material

[FY2014 Q3] Summary of Consolidated Financial Results

M3, Inc. to Acquire Neues Co., Ltd.: Evolving as Japan's Leading Comprehensive Clinical Trial Services Provider

[FY2014 Q2] M3 Presentation Material

～CSO Innovation: Development and Provision of Next Generation MRs～ Establishment of M3 Marketing

M3 China Membership Count Tops One Million Doctors

[FY2014 Q1] M3 Presentation Material

M3 Presentation Material

M3 Presentation material

About the Acquisition of MEDISCIENCE PLANNING INC. - Supplementary Material -

Notice regarding the execution of a stock exchange agreement related to M3 Inc.'s conversion of Mediscience Planning Inc. into its wholly owned subsidiary (short-form stock exchange)

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

M3 Presentation material

So-netM3 Presentation material

So-netM3 Presentation material

So-netM3 Presentation material

So-netM3 Presentation material